page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79
page 80
page 81
page 82
page 83
page 84
page 85
page 86
page 87
page 88
page 89
page 90
page 91
page 92
page 93
page 94
page 95
page 96
page 97
page 98
page 99
page 100
page 101
page 102
page 103
page 104
page 105
page 106
page 107
page 108
page 109
page 110
page 111
page 112
page 113
page 114
page 115
page 116
page 117
page 118
page 119
page 120
page 121
page 122
page 123
page 124
page 125
page 126
page 127
page 128
page 129
page 130
page 131
page 132
page 133
page 134
page 135
page 136
page 137
page 138
page 139
page 140
page 141
page 142
page 143
page 144
page 145
page 146
page 147
page 148
page 149
page 150
page 151
page 152
page 153
page 154
page 155
page 156
page 157
page 158
page 159
page 160
page 161
page 162
page 163
page 164
page 165
page 166
page 167
page 168
page 169
page 170
page 171
page 172
page 173
page 174
page 175
page 176
page 177
page 178
page 179
page 180
page 181
page 182
page 183
page 184
page 185
page 186

78INNOVATION UK MATCH and the NIC together with the participation of the innovator or clinical champion. With an increasing need to identify additional spending with metrics of patient benefit, the wider application of basic cost- effectiveness analysis has become necessary outside the usual expert base of health technology assess-ment specialists. In the context of the findings of the UK Health Industries Task Force, that a better assessment of value is required to bring new health technologies into the National Health Service, the tool described is seen to be facilitating a common understanding of value between healthcare decision- makers and medical device develop-ers or clinician " champions" who are amongst the first adopters of newly marketed devices. Further exemplar work is needed to examine the gener-alisability of the tool in terms of number and depth of decision- tree branches, balanced with a requirement to keep the model simple for non- expert use, and in the knowledge that data for a more complex model will be limited at the early stage of an innovation's develop-ment or deployment. As stated repeatedly, the tool is not intended to replace the need for a full NICE appraisal using a more complete data set, accepting that limited data will be the norm for early stage decisions. However more work needs to be done to examine the sensitivity to estimated data ranges and especially to research the effect on decisions from the making of optimistic or pes-simistic estimates. Conducting these exemplar studies with the tool on real users during its development prompted discussion about the " percentage cost modifier parameter". The rationale for inclusion of the feature was based on an example of a diagnostic device designed to assess burns by means of blood- flow measurement, where the treatment is a skin graft. If the innovation resulted in better assessment of the area in need of grafting, it was argued that this could be modelled as an efficiency saving in the treatment and therefore cost of treatment could be reduced accord-ingly. However, for general use it is perhaps too tempting to use it as a " fudge factor" to reduce the relative cost of the innovation. We have now decided to remove the feature and the user should enter cost savings to treat-ments directly. A major lesson learnt from the exemplar work is that lack of hard data is not a barrier to mutual understanding of value at the early stage of development or deployment of a medical technology innovation. We also found that data may exist but not be readily available, which sug-gests that wider deployment of the tool would ideally be supported by an accessible repository of data for the pur-poses of health economics evaluation. Most importantly the tool was developed in close partnership with its users. The close academic- industry- healthcare professional linkage facilitated by MATCH supports and actively pro-motes this kind of co- operative design approach. All of the focused evaluation meetings were carried out over a half- day period. However, some preparation is needed by all parties. Since conducting these exemplars, and after further consultations with partners in the medi-cal devices industry, we have identified that an introduc-tion to health economics, data sources and some hands-on training with the tool prior to the evaluation meeting would be beneficial. MATCH therefore decided to launch a series of tool workshops through the UK- wide Medilink network which brings together medical manufacturing and distribution companies, hospitals and universities to stimulate innovation on a regional basis. This is taking place alongside a new phase of exemplar studies with both NIC and PASA. This article is an abridged version of a paper first pub-lished in Journal of Management & Marketing in Healthcare Volume 2 Issue 3 ( September 2009). For further details visit http:// www. henrystewart. com/ jmmh For more information about this tool and other tools and methods developed by the Innovative Manufactur-ing Research Centre MATCH for use by Medical Device manufacturers, or for information about the benefits of becoming a MATCH Partner, please visit www. match. ac. uk or contact elizabeth. deadman@ brunel. ac. uk 1 NHS Institute for Innovation and Improvement, " Better Care, Better Value Indicators", http:// www. productivity. nhs. uk ( accessed Sep-tember 2008). 2 Healthcare Industries Task Force ( HITF) " Better health through partnership: A programme for action", 17 November 2004, http:// www. advisorybodies. doh. gov. uk/ hitf/ ( accessed August 2007). 3 Strategic Implementation Group ( SIG), Healthcare Industries Taskforce, Innovation for health: making a difference, 6 March 2007, http:// www. advisorybodies. doh. gov. uk/ hitf/ ( accessed August 2007). 4 NHS National Innovation Centre, Scorecard, http:// www. nic. nhs. uk/ Scorecard/ Pages/ Scorecard. aspx ( accessed October 2007) 5 Craven M., Crowe J., Botterill N., Morgan S. and Williams H., MATCH ( 2004): A multidisciplinary approach to the advancement of Health Technology Assessment, Proceedings of the Institute of Physics and Engineering in Medicine ( IPEM) 11th Annual Scientific Meeting, York, 6- 8 September 2004, p; 41, ISBN 1- 9036- 1323- X. First appeared in the Journal of Management & Marketing in Healthcare. VOL. 2 NO. 3. PP 1- 15. MONTH 2009 Healthcare match

INNOVATION UK79 Healthcare integrated technologies ltd Integrated Technologies Ltd - Bringing Instruments to Life At Integrated Technologies Ltd ( ITL) " Bringing Instruments to Life" isn't just a strap line; it is a way of thinking. ITL has over 35 years of experience in successful design, development, prototype and manufacture of instru-ments and devices for the medical, diagnostic, analytical and laboratory markets. We offer all the services of a design house, a regulatory consultancy and a manufac-turing facility under one roof and that makes a differ-ence to the way we think and the way we design. Our new product development cycle has been developed to consider the entirety of your product's life, not just one stage of the process, to turn a requirement into a final product. We find appropriate state- of- the- art practi-cal engineering solutions that can be progressed to our full- scale manufacturing facility. From the start of the design we are considering the manufacture of your prod-uct and have an insight into its future, and that means that the commercial reality is the focus throughout the development process. Behind every truly successful stylish design there is bril-liant engineering. Your product has its own set of mar-keting requirements such as beautiful styling, a clear easy- to- use interface and labelling and clever software. It may also have a set of functional requirements such as short time to result, unique disposable handling or a particular detection mechanism. Translating your basic requirements into a robust, cost- effective, easy- to- man-ufacture working solution is a skill of its own. At ITL we understand just how much elegance, sophistication and ergonomics are required to deliver an instrument that fits in today's marketplace. Working with you to make it hap-pen involves innovative thinking and a level of creativity along with trusted engineering. In fact graceful mecha-nisms, high- technology solutions and truly clever designs are what we are all about. Furthermore we understand that visual aesthetics of a product are very important and therefore our industrial design expertise ensures that our elegant engineering solutions are packaged into stylish overall designs. Full- scale manufacture is available from ITL both in the UK and in the Far East, not just for ITL designed products but also for products that are prototyped and ready for manufacture or already in manufacture. Highly skilled assembly, test and quality assurance processes are con-ducted within a cellular manufacturing environment alongside supply chain management and Kanban stock control systems. ITL has in- house PCB manufacture and in- line process control and inspection mechanisms and can undertake all aspects of product packaging, labelling and secure cargo shipping. Having dedicated in- house Production Engineering resource and access to Develop-ment Engineers enables smooth design- change control, obsolescence control and value engineering. Design and manufacture within a quality controlled envi-ronment is vital to the commercial success of a prod-uct in today's market. ITL is certified to ISO9001: 2000, BSEN 13485: 2003, FDA GMP 21 CFR part 820 making it the perfect place for design and manufacture of worldwide products. ITL offers you the opportunity to complete product development and manufacture within one organisation without the need to transfer knowledge between a design house, a prototyping company and a manufacturing facility. One company, one specification, one vision, one team, one system, one solution. How simple is that? For more information, contact: Integrated Technologies Ltd Viking House Ellingham Way Ashford Kent TN23 6NF Lucy Malby Website: www. itl. co. uk E- mail: sales@ itl. co. uk Tel: + 44 ( 0) 1233 638383 Design Prototype Manufacture